Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

Anti-androgens can help reduce the effects of male hormones on the skin.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Estrogen receptor α controls hair growth cycles and skin thickness in male mice.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Mutations in certain receptors can cause diseases and offer new treatment options.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Birth control pills can help reduce mild to moderate acne in women.

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.